Evidence map›Paper›PMID 34900472›Full record

ArticleCureus2021

Dilemma of Anticoagulation Therapy in Mild or Asymptomatic COVID-19 Cases.

Aditya Patel, Folasade Ajayi, Ruhma Ali, Kok Hoe Chan, Jihad Slim

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Aditya PatelInternal Medicine, Saint Michael's Medical Center, Newark, USA.
Folasade AjayiInternal Medicine, Saint Michael's Medical Center, Newark, USA.
Ruhma AliInternal Medicine, Saint Michael's Medical Center, Newark, USA.
Kok Hoe ChanInternal Medicine (Division of Hematology/Oncology), University of Texas Health Science Center at Houston, McGovern Medical School, Houston, USA.
Jihad SlimInfectious Diseases, Saint Michael's Medical Center, Newark, USA.
Saint Michael's Medical Center · USThe University of Texas Health Science Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) infection can be a life-threatening disease, which has emerged as a public health hazard. Thrombotic events have been reported in hospitalized patients with severe disease however scarce data is available regarding the screening of thromboembolic disease and pulmonary embolism in those with mild or asymptomatic infection. Herein, we describe the development of pulmonary embolism in two asymptomatic patients with COVID-19 and suggest the need for close monitoring and anticoagulation to prevent this life-threatening complication.

Indexed as

covid-19deep vein thrombosis (dvt)pulmonary embolism (pe)sars-cov-2 (severe acute respiratory syndrome coronavirus -2)therapeutic anticoagulation

Identifiers

PMID34900472
PMCPMC8648285
OpenAlexW3212624506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.